Intra Cellular Therapies | Kortsiktig Gjeld

Current Liabilities Endring Dato
Acadia Pharmaceuticals USD 254.25M 44.65M 2023-12
ALKERMES USD 503.11M 15.92M 2023-09
Biogen USD 3.43B 1.59B 2023-12
Bristol-Myers Squibb USD 23.46B 3.31B 2023-09
Cytokinetics USD 102.68M 24.96M 2023-12
Gilead Sciences USD 11.28B 665M 2023-12
Halozyme Therapeutics USD 112.49M 2.69M 2023-12
Intra Cellular Therapies USD 123.54M 20.45M 2023-12
Neurocrine Biosciences USD 691.6M 109.1M 2023-09
RedHill Biopharma USD 28.19M 20.25M 2023-06
Supernus Pharmaceuticals USD 290.2M 2.66M 2023-12
United Therapeutics USD 804.4M 60.3M 2023-12



Intra Cellular Therapies Kortsiktig Gjeld - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.